Interleukin inhibitors

Actemra 162 mg/0.9 mL ACTPen® autoinjector Images

Generic Name: tocilizumab

This medication has been identified as Actemra 162 mg/0.9 mL ACTPen® autoinjector. It is supplied by Genentech, Inc.

Actemra is used in the treatment of Giant Cell Arteritis; Cytokine Release Syndrome; Rheumatoid Arthritis; Juvenile Idiopathic Arthritis; Systemic Sclerosis-Associated Interstitial Lung Disease and belongs to the drug class interleukin inhibitors. Risk cannot be ruled out during pregnancy. Actemra 162 mg/0.9 mL ACTPen® autoinjector is not a controlled substance under the Controlled Substances Act (CSA).

Images

Actemra actpen (Tocilizumab [ toe-si-liz-oo-mab ])-medicine-162 mg/0.9 mL ACTPen® autoinjector

Actemra actpen
Generic Name: tocilizumab [ toe-si-liz-oo-mab ]
Imprint: medicine
Strength: 162 mg/0.9 mL ACTPen® autoinjector
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: Interleukin inhibitors
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 50242-0143
Inactive Ingredients:
Latest News
Related Drugs